Exploring the benefits of park visits for individuals with dementia and their caregivers

Examining the Effects of an 8-Week Open Label Nature-Based Park Visit Program on the Quality of Life, Behaviors and Cognitive Symptoms of Individuals With Dementia and Their Caregivers

NA · University of Calgary · NCT05527587

This study is testing whether an 8-week program of visiting nature parks can improve the quality of life for people with mild to moderate dementia and their caregivers.

Quick facts

PhaseNA
Study typeInterventional
Enrollment20 (estimated)
Ages65 Years and up
SexAll
SponsorUniversity of Calgary (other)
Locations1 site (Calgary, Alberta)
Trial IDNCT05527587 on ClinicalTrials.gov

What this trial studies

This project aims to assess the effects of an 8-week nature park visit program on individuals living with mild to moderate dementia and their caregivers. Participants will receive education on the benefits of outdoor activities and will engage in weekly support meetings to share experiences and address challenges. The study will evaluate the impact of these park visits on quality of life, neuropsychiatric symptoms, cognition, and stress levels. By focusing on non-pharmacological interventions, the study seeks to enhance the well-being of both patients and caregivers.

Who should consider this trial

Good fit: Ideal candidates include individuals aged 65 and older with mild to moderate dementia who currently engage in limited outdoor activities.

Not a fit: Patients with unstable medical conditions that prevent outdoor activities or those residing in long-term care facilities may not benefit from this study.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life and mental health of individuals with dementia and their caregivers.

How similar studies have performed: While there is limited evidence specifically on nature-based activities for dementia, previous studies have shown positive outcomes from non-pharmacological interventions in similar populations.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and female participants who are 65 years or older
* PLWD who meet Diagnostics and Statistical Manual of Mental Disorders DSM-5 for major neurocognitive disorder due to Alzheimer's disease
* Individuals with mild to moderate dementia as assessed on the Montreal Cognitive Assessment (MoCA) corresponding to scores of 12-25 on the 12-item assessment or 10-18 on the 9-item telephone MoCA assessment
* Participants who currently participate in less than 2 hours of outdoor activities weekly using the Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire
* Caregivers who spend at least 2 hours per week with PLWD
* Participants that are able to mobilize independently or with assistive devices and have the ability access local parks either independently or with the assistance of caregivers.

Exclusion Criteria:

* Participants with unstable conditions that prevent outdoor activities
* Patients residing in long-term care or nursing homes
* Individuals with AD who have no access to a caregiver
* Participants with limited mobility that prevents outdoor activities
* Participants who do not have adequate comprehension and verbal communication in English necessary to participate in measurement of outcomes.

Where this trial is running

Calgary, Alberta

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Mild Dementia, Moderate Dementia, Alzheimer Disease, Dementia, Nature, Outdoor activities, Mental health, Alzheimer's disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.